Better Therapeutics Inc
Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease… Read more
Better Therapeutics Inc (BTTX) - Total Assets
Latest total assets as of September 2023: $10.72 Million USD
Based on the latest financial reports, Better Therapeutics Inc (BTTX) holds total assets worth $10.72 Million USD as of September 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Better Therapeutics Inc - Total Assets Trend (2019–2022)
This chart illustrates how Better Therapeutics Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Better Therapeutics Inc - Asset Composition Analysis
Current Asset Composition (December 2022)
Better Therapeutics Inc's total assets of $10.72 Million consist of 80.4% current assets and 19.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 68.6% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $121.00K | 0.5% |
| Intangible Assets | $3.89 Million | 17.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2019–2022)
This chart illustrates how Better Therapeutics Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Better Therapeutics Inc's current assets represent 80.4% of total assets in 2022, an increase from 20.2% in 2019.
- Cash Position: Cash and equivalents constituted 68.6% of total assets in 2022, up from 15.5% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 16.0% of total assets, a decrease from 66.0% in 2019.
- Asset Diversification: The largest asset category is intangible assets at 17.0% of total assets.
Better Therapeutics Inc Competitors by Total Assets
Key competitors of Better Therapeutics Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Better Therapeutics Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Better Therapeutics Inc generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Better Therapeutics Inc is currently not profitable relative to its asset base.
Better Therapeutics Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.57 | 2.52 | 0.96 |
| Quick Ratio | 0.57 | 2.52 | 0.96 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-5.59 Million | $ 14.18 Million | $ -1.00K |
Better Therapeutics Inc - Advanced Valuation Insights
This section examines the relationship between Better Therapeutics Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.29 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -55.0% |
| Total Assets | $22.94 Million |
| Market Capitalization | $2.45K USD |
Valuation Analysis
Below Book Valuation: The market values Better Therapeutics Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Better Therapeutics Inc's assets decreased by 55.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Better Therapeutics Inc (2019–2022)
The table below shows the annual total assets of Better Therapeutics Inc from 2019 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | $22.94 Million | -54.98% |
| 2021-12-31 | $50.96 Million | +697.84% |
| 2020-12-31 | $6.39 Million | +30.85% |
| 2019-12-31 | $4.88 Million | -- |